|
|
|||||||||||
The British Journal of Psychiatry 137: 240-244 (1980)
© 1980 The Royal College of Psychiatrists
A Lautin, B Angrist, M Stanley, S Gershon, K Heckl and M Karobath
Sodium valproate given in doses of 750-3000 mg daily to eight schizophrenic patients produced a qualitatively similar increase in symptoms in five. CSF showed no significant change in gamma-amino- butyric acid or methoxy hydroxyphenyl glycol, but homovanillic acid increased non-significantly in five patients.
This article has been cited by other articles:
![]() |
L. Citrome, J. Levine, and B. Allingham Changes in Use of Valproate and Other Mood Stabilizers for Patients With Schizophrenia From 1994 to 1998 Psychiatr Serv, May 1, 2000; 51(5): 634 - 638. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |